Ping Wu
- Cancer Research top 5%
- NF-κB Signaling Pathways 5
- Immunology top 5%
- Immunotherapy and Immune Responses 3
- Galectins and Cancer Biology 3
- Nephrology top 5%
- Immunology and Allergy top 10%
- Rheumatology top 10%
- Systemic Lupus Erythematosus Research 4
-
- Prostate Cancer Treatment and Research 5
-
- Cardiac Imaging and Diagnostics 4
- Monoclonal and Polyclonal Antibodies Research 4
-
- Inflammatory Bowel Disease 3
- Co-authors
- Linda C. BurklyUlf‐Håkan StenmanJari LeinonenJennifer S. MichaelsonHannu KoistinenMartin ScottAnna BorodovskyXingwen Dong
- Cited by
- Cancer ResearchImmunologyNephrology
- Partner nations
- ChinaUnited StatesFinland
In The Last Decade
Ping Wu
64 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 121
- Cancer Research 352
- Immunology 466
- Nephrology 130
- Immunology and Allergy 64
- Rheumatology 149
Countries citing papers authored by Ping Wu
This map shows the geographic impact of Ping Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ping Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ping Wu more than expected).
Fields of papers citing papers by Ping Wu
This network shows the impact of papers produced by Ping Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ping Wu. The network helps show where Ping Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ping Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 1 | |
| 6 | 2017 | 56 | |
| 7 | 2016 | 21 | |
| 8 | 2014 | 25 | |
| 9 | 2014 | 77 | |
| 10 | 2013 | 2 | |
| 11 | Study on Pedestrian Traffic Characteristics of Transfer Hubs in Beijing | 2010 | 4 |
| 12 | 2009 | 1 | |
| 13 | 2008 | 177 | |
| 14 | 2008 | 32 | |
| 15 | 2008 | 41 | |
| 16 | 2006 | 25 | |
| 17 | 2004 | 15 | |
| 18 | 2003 | 29 | |
| 19 | 2002 | 40 | |
| 20 | 2000 | 69 |
About Ping Wu
Ping Wu is a scholar working on Nephrology, Cancer Research, Immunology, Rheumatology and Radiology, Nuclear Medicine and Imaging, having authored 66 papers that have together received 1.5k indexed citations. Recurring topics across this work include NF-κB Signaling Pathways (5 papers), Prostate Cancer Treatment and Research (5 papers), Cardiac Imaging and Diagnostics (4 papers), Systemic Lupus Erythematosus Research (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Immunotherapy and Immune Responses (3 papers), Inflammatory Bowel Disease (3 papers) and Galectins and Cancer Biology (3 papers). The work is most often cited by research in Cancer Research (352 citations), Immunology (466 citations), Nephrology (130 citations), Immunology and Allergy (64 citations) and Rheumatology (149 citations). Ping Wu has collaborated with scholars based in China, United States and Finland. Frequent co-authors include Linda C. Burkly, Ulf‐Håkan Stenman, Jari Leinonen, Jennifer S. Michaelson, Hannu Koistinen, Martin Scott, Anna Borodovsky, Xingwen Dong, Erkki Koivunen and Timothy S. Zheng. Their work appears in journals such as The Prostate, Biological Chemistry, Gastroenterology, Mucosal Immunology and Acta Pharmaceutica Sinica B.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.